Fluoroscopy confirming no signs of paravalvular leak after a successful valve-in-valve caval valve implantation. Image courtesy of Jennifer von Stein, MD, et al. and JACC: Cardiovascular Interventions.
A care team in Germany has completed what may be the first structural heart procedure of its kind on a high-risk patient. It started as a straightforward heterotopic caval valve implantation, but then paravalvular leak resulted in a change of plans.
There is no application process, eligible physicians are automatically approved. In order to earn “gold card status” a practice must have a prior authorization approval rate of 92% or higher for at least the last two years.
An example of HeartFlow's new RoadMap Stenosis software that uses artificial intelligence (AI) to show areas of interest for possible stenting based on a patient's CT scan and FFR-CT. The software was rolled out commercially in April 2023.
At its current rate, the number of clinical AI models cleared by the FDA will break 1,000 before the end of 2024. Cardiology continues to play a significant role in this ongoing trend.
Paradise Ultrasound image courtesy of Recor Medical.
Physicians using the Paradise Ultrasound Renal Denervation system from Recor Medical or Symplicity Spyral Renal Denervation system from Medtronic will soon be eligible for a much more significant reimbursement when treating Medicare patients in an inpatient setting.
Capitol Radiology had hoped to halt a new center from opening in Laurel, Maryland, contending it would have a “substantially adverse effect” on its business.
